| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,274,600 | 1,111,000 | 1,012,400 | 1,087,600 | | Cost of Revenue | 814,000 | 717,200 | 738,500 | 849,100 | | | Gross Profit | 460,600 | 393,800 | 273,900 | 238,500 | | | Operating Expenses | | Research Development | 54,800 | 49,200 | 49,000 | 55,300 | | Selling General and Administrative | 128,200 | 101,300 | 93,800 | 96,200 | | Non Recurring | 5,800 | 15,300 | 6,200 | 376,900 | | Others | 6,300 | 6,200 | 6,300 | 6,200 | | | | Total Operating Expenses | 195,100 | 172,000 | 155,300 | 534,600 | | | | Operating Income or Loss | 265,500 | 221,800 | 118,600 | (296,100) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,200 | 1,600 | 2,700 | 17,200 | | Earnings Before Interest And Taxes | 274,700 | 223,400 | 121,300 | (278,900) | | Interest Expense | 26,500 | 27,500 | 29,400 | 17,900 | | Income Before Tax | 248,200 | 195,900 | 91,900 | (296,800) | | Income Tax Expense | 73,500 | 60,000 | 26,700 | (15,800) | | Minority Interest | (9,200) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 165,500 | 135,900 | 65,200 | (281,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 165,500 | 135,900 | 65,200 | (281,000) | | Preferred Stock And Other Adjustments | 5,000 | (4,000) | (1,000) |
-
| | | Net Income Applicable To Common Shares | $170,500 | $131,900 | $64,200 | ($281,000) |
|
1.38% Nasdaq 
Income Statement
